tradingkey.logo
tradingkey.logo
Search

Edgewise Therapeutics Inc

EWTX
Add to Watchlist
38.430USD
-2.690-6.54%
Close 07-31 16:00ETQuotes delayed by 15 min
4.08BMarket Cap
LossP/E TTM

EWTX Financials

See Edgewise Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Edgewise Therapeutics Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-0.46/-0.49
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.63
-12.58%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-6.69%-0.46
-13.11%-0.47
-5.96%-0.39
-2.18%-0.34
-31.66%-0.43
10.02%-0.42
10.21%-0.36
0.57%-0.34
9.76%-0.33
-51.79%-0.47
---0.41
---0.34
---0.36
---0.31
---0.96
----
----
----
----
----
Net Profit
-20.14%-49.01M
-26.61%-50.22M
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.80M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.50M
-24.90%-28.52M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-52.92%-19.41M
-35.13%-17.50M
-55.19%-16.07M
-115.11%-14.66M
-100.19%-12.70M
-255.55%-12.95M
-161.84%-10.35M
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.02%
----
----
----
----
----
Operating profit
-17.75%-54.12M
-22.92%-55.98M
-15.89%-46.86M
-11.82%-42.61M
-32.24%-45.96M
-34.49%-45.54M
-37.28%-40.43M
-50.39%-38.11M
-35.20%-34.75M
-53.37%-33.86M
-61.27%-29.45M
-53.65%-25.34M
-73.37%-25.70M
-72.20%-22.08M
-39.66%-18.26M
-57.66%-16.49M
-116.22%-14.83M
-102.11%-12.82M
-258.93%-13.08M
-164.34%-10.46M
Net Profit
-20.14%-49.01M
-26.61%-50.22M
-19.15%-40.67M
-14.66%-36.12M
-43.03%-40.80M
-31.58%-39.66M
-32.73%-34.13M
-46.71%-31.50M
-24.90%-28.52M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-52.92%-19.41M
-35.13%-17.50M
-55.19%-16.07M
-115.11%-14.66M
-100.19%-12.70M
-255.55%-12.95M
-161.84%-10.35M
Current assets
15.03%509.79M
14.28%543.38M
14.91%573.90M
16.14%603.25M
-18.15%443.18M
45.41%475.48M
67.64%499.44M
63.86%519.44M
62.41%541.43M
-8.40%327.00M
-19.51%297.92M
25.13%317.00M
24.10%333.36M
25.80%357.00M
26.22%370.14M
-16.38%253.34M
-13.50%268.62M
--283.77M
--293.24M
--302.97M
Total current liabilities
6.76%22.54M
14.71%27.37M
14.18%21.65M
21.66%20.90M
44.62%21.11M
42.27%23.86M
16.03%18.96M
19.28%17.18M
14.83%14.60M
1.12%16.77M
22.81%16.34M
56.25%14.40M
27.10%12.71M
57.64%16.59M
51.96%13.30M
36.76%9.22M
106.23%10.00M
--10.52M
--8.75M
--6.74M
Total assets
14.11%518.52M
13.51%552.60M
14.12%583.47M
15.36%613.33M
-17.95%454.39M
43.17%486.82M
64.21%511.28M
60.80%531.65M
59.87%553.81M
-7.37%340.04M
-17.44%311.36M
28.45%330.63M
27.01%346.40M
28.70%367.10M
28.09%377.15M
-15.19%257.40M
-12.37%272.75M
--285.23M
--294.45M
--303.49M
Total liabilities
2.62%25.32M
9.95%30.35M
10.77%24.82M
14.59%24.26M
30.78%24.67M
30.16%27.60M
7.01%22.41M
10.45%21.17M
7.43%18.86M
4.02%21.20M
32.94%20.94M
73.58%19.17M
41.74%17.56M
87.88%20.39M
74.04%15.75M
63.88%11.04M
155.39%12.39M
--10.85M
--9.05M
--6.74M
Total equity
14.77%493.20M
13.73%522.26M
14.27%558.65M
15.40%589.07M
-19.67%429.72M
44.03%459.22M
68.33%488.88M
63.90%510.47M
62.68%534.94M
-8.04%318.83M
-19.64%290.43M
26.43%311.45M
26.30%328.84M
26.36%346.72M
26.63%361.40M
-16.98%246.35M
-15.03%260.36M
--274.38M
--285.40M
--296.75M
Net operating income
-12.35%-42.54M
-43.16%-38.59M
-27.04%-34.78M
-24.84%-32.58M
-32.41%-37.87M
-0.47%-26.96M
-24.10%-27.37M
-28.99%-26.10M
-25.29%-28.60M
-126.99%-26.83M
-83.85%-22.06M
-24.56%-20.23M
-81.56%-22.83M
-25.49%-11.82M
-45.22%-12.00M
-66.29%-16.25M
-107.56%-12.57M
-103.08%-9.42M
-152.51%-8.26M
-145.14%-9.77M
Net investment
-94.46%2.43M
137.85%49.76M
40.82%35.72M
-533.97%-162.17M
116.36%43.90M
-22.46%20.92M
8.30%25.36M
985.65%37.37M
-647.10%-268.31M
135.69%26.98M
188.97%23.42M
7582.61%3.44M
56.25%49.04M
-635.34%-75.60M
16.73%-26.32M
99.97%-46.00K
148.46%31.39M
158.40%14.12M
-526700.00%-31.61M
-84988.83%-159.97M
Net financing
447.59%12.17M
37.31%3.98M
-50.23%1.66M
9542.98%188.23M
-99.08%2.22M
-94.54%2.90M
1679.62%3.33M
429.00%1.95M
1147866.67%241.07M
15776.63%52.99M
-100.16%-211.00K
106.15%369.00K
-71.23%21.00K
-215.36%-338.00K
350508.11%129.72M
119.98%179.00K
-99.96%73.00K
-99.69%293.00K
-99.85%37.00K
-763.70%-896.00K

FAQs

What are the current assets of Edgewise Therapeutics Inc?

According to Edgewise Therapeutics Inc's FY2025 earnings report, its current assets were 543.38M, with a year-on-year change of 14.28.

What are the total assets of Edgewise Therapeutics Inc?

According to Edgewise Therapeutics Inc's FY2025 earnings report, its total assets of Edgewise Therapeutics Inc were 552.60M, with a year-on-year change of 13.51.

What are the total liabilities of Edgewise Therapeutics Inc?

According to Edgewise Therapeutics Inc's FY2025 earnings report, its total liabilities of Edgewise Therapeutics Inc were 30.35M, with a year-on-year change of 9.95.

What is the total equity of Edgewise Therapeutics Inc?

According to Edgewise Therapeutics Inc's FY2025 earnings report, its total equity of Edgewise Therapeutics Inc was 522.26M, with a year-on-year change of 13.73.

What is the net operating income of Edgewise Therapeutics Inc?

According to Edgewise Therapeutics Inc's FY2025 earnings report, its net operating income of Edgewise Therapeutics Inc was -191.41M, with a year-on-year change of -20.51.

What is the net investment of Edgewise Therapeutics Inc?

According to Edgewise Therapeutics Inc's FY2025 earnings report, its net investment of Edgewise Therapeutics Inc was -32.79M, with a year-on-year change of 82.24.

What is the net financing of Edgewise Therapeutics Inc?

According to Edgewise Therapeutics Inc's FY2025 earnings report, its net financing of Edgewise Therapeutics Inc was 196.09M, with a year-on-year change of -21.33.

What is the Earnings Per Share (EPS) of Edgewise Therapeutics Inc?

According to Edgewise Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.63, with a year-on-year change of -12.58.

What is the net income of Edgewise Therapeutics Inc?

According to Edgewise Therapeutics Inc's FY2025 earnings report, its net income was -167.79M, with a year-on-year change of -25.40.

What is the Return on Equity (ROE) of Edgewise Therapeutics Inc?

According to Edgewise Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -34.19, with a year-on-year change of 0.60.

What is the Return on Assets (ROA) of Edgewise Therapeutics Inc?

According to Edgewise Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -32.29, with a year-on-year change of 0.25.

What is the operating profit of Edgewise Therapeutics Inc?

According to Edgewise Therapeutics Inc's FY2025 earnings report, its operating profit was -191.41M, with a year-on-year change of -20.51.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.